Keppra Concentrate for Solution for Infusion 100 mgml Singapore - English - HSA (Health Sciences Authority)

keppra concentrate for solution for infusion 100 mgml

glaxosmithkline pte ltd - levetiracetam - infusion, solution concentrate - 500 mg per vial - levetiracetam 500 mg per vial

Keppra Oral Solution 100 mgml Singapore - English - HSA (Health Sciences Authority)

keppra oral solution 100 mgml

glaxosmithkline pte ltd - levetiracetam - solution - 100 mg/ml - levetiracetam 100 mg/ml

KEPPRA TABLET 1000 mg Singapore - English - HSA (Health Sciences Authority)

keppra tablet 1000 mg

glaxosmithkline pte ltd - levetiracetam - tablet, film coated - 1000 mg - levetiracetam 1000 mg

KEPPRA TABLET 250 mg Singapore - English - HSA (Health Sciences Authority)

keppra tablet 250 mg

glaxosmithkline pte ltd - levetiracetam - tablet, film coated - 250 mg - levetiracetam 250 mg

KEPPRA TABLET 500 mg Singapore - English - HSA (Health Sciences Authority)

keppra tablet 500 mg

glaxosmithkline pte ltd - levetiracetam - tablet, film coated - 500 mg - levetiracetam 500 mg

KEPPRA 250 MG Israel - English - Ministry of Health

keppra 250 mg

cts ltd - levetiracetam - film coated tablets - levetiracetam 250 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

KEPPRA 500 MG Israel - English - Ministry of Health

keppra 500 mg

cts ltd - levetiracetam - film coated tablets - levetiracetam 500 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

KEPPRA 1000 MG Israel - English - Ministry of Health

keppra 1000 mg

cts ltd - levetiracetam - film coated tablets - levetiracetam 1000 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

KEPPRA ORAL SOLUTION Israel - English - Ministry of Health

keppra oral solution

cts ltd - levetiracetam - solution - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. keppra is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

LEVETIRACETAM AUROBINDO 250 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

levetiracetam aurobindo 250 milligram film coated tablet

milpharm limited - levetiracetam - film coated tablet - 250 milligram - other antiepileptics